JNJ
A tiny trim, not a full-on exit
Norris Perne & French LLP MI shaved 5,272 shares off its Johnson & Johnson position, leaving it with about 186,600 shares worth roughly $38.6 million. That’s the financial equivalent of taking one scoop out of a full pint — noticeable, sure, but not exactly a panic dump.
The real headline is still the quarter
If you’re looking for the market-moving stuff, it’s not the portfolio trim. J&J just posted Q1 revenue of $24.06 billion, up 9.9% year over year, and earned $2.70 per share, edging past Wall Street’s $2.68 estimate. Then it did the corporate version of saying “and one more thing…” by raising full-year 2026 EPS guidance to $11.45 to $11.65.
Dividend investors, take a bow
J&J also lifted its quarterly dividend to $1.34 from $1.30. That bumps the annual payout to $5.36 a share and keeps the stock wearing its “boring but dependable” crown a little more snugly. In a market where a lot of companies are still trying to figure out what they want to be when they grow up, J&J keeps showing up with cash flow and a checkbook.
Why you should care
Institutional selling can sometimes hint at changing sentiment, but this looks more like routine portfolio housekeeping than a thesis-shattering move. The bigger investor takeaway is that J&J is still flashing the classic combo meal: growth, guidance, and income — not bad for a company everyone likes to call sleepy.
Big picture: a small stake trim is background noise; the earnings beat and dividend raise are the actual drumbeat.